- Deflazacort for Type-1 Autoimmune Hepatitis in a Korean Girl
-
Bae SH, Kim JS, Kim DH
- KMID: 2157835
- J Korean Med Sci.
- 2006 Aug;21(4):758-760.
- doi: 10.3346/jkms.2006.21.4.758
Prednisone or prednisolone are the mainstay drug treatments for autoimmune hepatitis in children. However, long-term use of corticosteroid is associated with the risk of steroid-induced toxicities, and this situation requires... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Treatment Outcomes for Autoimmune Hepatitis in Korea
-
Kil JS, Lee JH, Han AR, Kang JY, Won HJ, Jung HY, Lim HM, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC
- KMID: 1713832
- J Korean Med Sci.
- 2010 Jan;25(1):54-60.
- doi: 10.3346/jkms.2010.25.1.54
Immunosuppressive therapy can improve clinical, biochemical and histological features and considerably prolong survival in patients with autoimmune hepatitis. Although ethnicity may affect disease severity and presentation, the long-term outcome of... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in the Adverse Effects of Azathioprine between Inflammatory Bowel Disease and Autoimmune Hepatitis in Korean Patients
-
Lee YJ, Choi WY, Park KS, Kim YJ, Cho KB, Kim ES, Jang BK, Chung WJ, Hwang JS
- KMID: 2160667
- Korean J Gastroenterol.
- 2014 Dec;64(6):348-355.
- doi: 10.4166/kjg.2014.64.6.348
BACKGROUND/AIMS: Azathioprine (AZA) has been widely used in the therapy of inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH). However, studies evaluating the adverse effects of AZA in these two... -
- CITED
-
- Close
- SHARE
-
- Close
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
-
Park SW, Um SH, Lee HA, Kim SH, Sim Y, Yim SY, Seo YS, Ryu HS
- KMID: 2373126
- Clin Mol Hepatol.
- 2016 Jun;22(2):281-285.
- doi: 10.3350/cmh.2015.0040
Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease characterized by hepatocellular inflammation, necrosis, and fibrosis, which can progress to cirrhosis and fulminant hepatic failure. The standard treatment for AIH... -
- CITED
-
- Close
- SHARE
-
- Close
